This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Voronoi Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yikyung Ko: Inventor in Pharmaceutical Research
Introduction
Yikyung Ko is an inventor based in Incheon, South Korea, and is associated with Voronoi Inc. His work includes a patent for a compound intended for cancer prevention or treatment. He is credited with 1 patent.
Latest Patents
Ko’s listed patent is “Heteroaryl Derivative, Method for Preparation Thereof, and Pharmaceutical Composition Comprising Same as Active Ingredient.” The invention describes a pharmaceutical composition containing the compound, an isomer, hydrate, solvate, or pharmaceutically acceptable salt as an active ingredient.
According to the patent description, the compound exhibits inhibitory activity against epidermal growth factor receptor (EGFR) mutants and at least one form of ErbB2 or ErbB4, including wild-type or mutant forms. The composition is proposed for treating cancers that express these targets.
Career Highlights
Ko’s patent work is associated with Voronoi Inc. and focuses on pharmaceutical research involving compounds that target cancer-related receptors.
Collaborations
Younho Lee and Juhee Kang are identified as Ko’s coworkers.
Conclusion
Yikyung Ko’s listed invention concerns a potential cancer-treatment composition designed to inhibit EGFR and ErbB-family targets, reflecting his contribution to pharmaceutical innovation at Voronoi Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile